Sechenov Medical Journal

Advanced search

Depressive disorder and quality of life in patients with cerebral microangiopathy


The association between depressive disorder and quality of life of middle-aged patients with cerebral microangiopathy has not been fully investigated.

Aim. Study the association between the depression level and quality of life (QOL) in patients with cerebral microangiopathy.

Materials and methods. In outpatients 45–59 years old (n = 262, 42% men, 58% women) with cerebral microangiopathy and depression, the level of anxiety was assessed using the HADS-A scale, QOL — using the SF-36 questionnaire. According to the severity of depression (HADS-D subscale), the following were distinguished: group 1 (n = 116) — 8–10 points (subclinical) and group 2 (n = 146) — ≥11 points (clinical). To analyze the data used: t-test, correlation coefficient, logistic regression model; odds ratio (OR) and 95% confidence interval (CI).

Results. In group 2, the average anxiety score on the HADS-A scale was 14.3 ± 4.6 points, and for anhedonia was – 10.4 ± 4.2 points, which is statistically significantly higher than in group 1: 10.1 ± 4.2 and 7.1 ± 2.6 points, respectively (p < 0.05). The overall QOL score was statistically significantly lower in group 2: according to the physical component of health, 52.4 ± 26.5 vs. 88.8 ± 43.5 in group 1 (p < 0.05) and psychological component 38.5 ± 19.4 vs. 70.8 ± 35.8 in group 1 (p < 0.05). Depression, anxiety and anhedonia are associated with a negative effect on the overall QOL: r = −0.84 (p < 0.05), r = −0.81 (p < 0.05), r = −0.87 (p < 0.05), respectively. This association does not depend on age, obesity, type 2 diabetes mellitus: OR for depression was 2.1; 95% CI (1.8–2.4), p < 0.05; anxiety — 1.9; 95% CI (1.2–2.2), p < 0.05; anhedonia — 2.3; 95% CI (2.1–2.7), p < 0.05, respectively.

Conclusion. Clinically significant depression reduces noticeably QOL. An increase in the severity of affective symptoms leads to a deterioration in both the psychological and physical components of QOL. Decreased QOL does not depend on age, obesity, type 2 diabetes mellitus.

About the Authors

O. V. Vorob’eva
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Olga V. Vorob’eva, MD, PhD, DMSc, Professor, Department of Nervous Diseases, Department of General Medical Practice

8/2, Trubetskaya str., Moscow, 119991

V. V. Fateeva
Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Victoria V. Fateeva, Postgraduate, Department of Nervous Diseases

8/2, Trubetskaya str., Moscow, 119991
Tel.: +7 (926) 090-23-55 


1. Voznesenskaya T.G. Depressii v nevrologicheskoi praktike. [Depression in neurological practice]. Trudnyy patsiyent. 2003; 1(2): 26–30 (In Russian).

2. Vorob’eva O.V. Klinicheskie osobennosti depressii v obshchemeditsinskoi praktike (po rezul’tatam programmy «Kompas»). [Clinical features of depression in general medical practice (according to the results of the «Compas» program)]. Consilium Medicum. 2004; 6(2): 154−58 (In Russian).

3. Krasnov V.N. Trevozhno-depressivnye rasstroistva u patsientov pervichnoi meditsinsko seti. [Anxiety-depressive disorders in patients of the primary medical network]. Medvestnik. 2010 (In Russian). URL: (accessed: 10.05.2020)

4. Аlеxоpоulоs G.S., Mеyеrs B.S., Yоung R.С., et al. «Vаsсulаr dеprеssiоn» hypоthеsis. Аrсh Gеn Psyсhiаtry. 1997; 54: 915–22.аrсhpsyс.1997.01830220033006 PMID: 9337771

5. Yakhno N.N., Levin O.S., Damulin I.V. Sopostavlenie klinicheskikh i MRT-dannykh pri distsirkulyatornoi ehntsefalopatii. Soobshchenie 2: kognitivnye narusheniya. [Comparison of clinical and MRI data for discirculatory encephalopathy. Message 2: cognitive impairment]. Nevrologicheskii zhurnal. 2001; 6(3): 10–9 (In Russian).

6. Harwood D., Hawton K., Hope T., Jacob R. Psychiatric disorder and personality factors associated with suicide in older people: a descriptive and case-control study. Int J Geriatr Psychiatry. 2001; 16(2): 155–65.<155::aid-gps289>;2-0 PMID: 11241720

7. Vorob’eva O.V. Val’doksan v terapii depressii v nevrologicheskoi praktike: rezul’taty rossiiskogo mnogotsentrovogo naturalisticheskogo issledovaniya “Rezonans”. [Valdoxan in the treatment of depression in neurological practice: the results of the Russian multicenter naturalistic study “Resonance”]. S.S. Korsakov Journal of Neurology and Psychiatry. 2012; 112(9): 47–51 (In Russian).

8. Cooper J.A., Arulpragasam A.R., Treadway M.T. Anhedonia in depression: biological mechanisms and computational models. Curr Opin Behav Sci. 2018; 22: 128–35. PMID: 29503842

9. Brenes G.A. Anxiety, depression, and quality of life in primary care patients. Prim Care Companion J Clin Psychiatry. 2007; 9(6): 437–43. PMID: 18185823

10. Wardlaw J.M., Smith E.E., Biessels G.J., et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12: 822–38. PMID: 23867200

11. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6): 361−70. PMID: 6880820

12. Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health Survey. Manual and interpretation guide. The Health Institute, New England Medical Center. Boston, Mass. 1993.

13. Melikyan E.G., Gekht A.B. Kachestvo zhizni bol’nykh ehpilepsiei. [Quality of life of patients with epilepsy]. Lechebnoye delo. 2011; 1: 1–9 (In Russian).

14. Boyko O.V., Tatarinova M.Yu., Popova E.V., et al. Uluchshenie pokazatelei kachestva zhizni bol’nykh rasseyannym sklerozom za 15-letnii period. [Improving the quality of life of patients with multiple sclerosis over a 15-year period]. S.S. Korsakov Journal of Neurology and Psychiatry. Special issues. 2018; 118(8): 23–8 (In Russian).

15. Vorob’eva O.V., Fateeva V.V., Ivanova T.A. Vliyanie kognitivnykh i affektivnykh narushenii, assotsiirovannykh s khronicheskoi sosudistoi mozgovoi nedostatochnost’yu, na kachestvo zhizni bol’nykh. [Influence of cognitive and affective disorders associated with chronic cerebrovascular insufficiency on the quality of life of patients]. S.S. Korsakov Journal of Neurology and Psychiatry. 2014; 114(8): 158–9 (In Russian).

16. Baker J.G., Williams A.J., Ionita C.C., et al. Cerebral small vessel disease: cognition, mood, daily functioning, and imaging findings from a small pilot sample. Dement Geriatr Cogn Dis Extra. 2012; 2(1): 169–79. PMID: 22590477

17. Amirdjanova V.N., Goryachev D.V., Korshunov N.I., et al. Populyatsionnye pokazateli kachestva zhizni po oprosniku SF-36 (rezul’taty mnogotsentrovogo issledovaniya kachestva zhizni “MIRAZH”). [Population indicators of quality of life according to the SF-36 questionnaire (results of a multicenter study of the quality of life “MIRAGE”)]. Rheumatology Science and Practice. 2008; 46(1): 36–48 (In Russian).

18. Zakharov V.V. Depressiya pri sosudistykh zabolevaniyakh golovnogo mozga. [Depression in vascular diseases of the brain]. Ehffektivnaya farmakoterapiya. Nevrologiya. 3(31) (In Russian). evaniyakh_golovnogo_mozga.html (accessed 07.04.2020)

19. Gorwood P. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 2008; 10(3): 291–99. PMID: 18979942

20. Höflich A., Michenthaler P., Kasper S., Lanzenberger R. Circuit Mechanisms of Reward, Anhedonia, and Depression. Int J Neuropsychopharmacol. 2019; 22(2): 105–18. PMID: 30239748

21. Dai L., Zhou H., Xu X., Zuo Z. Brain structural and functional changes in patients with major depressive disorder: a literature review. PeerJ. 2019; 7: e8170. PMID: 31803543

22. Cuijpers P., Koole S.L., van Dijke A., et al. Psychotherapy for s clinical depression: meta-analysis. Br J Psychiatry. 2014; 205(4): 268–74. PMID: 25274315

23. Barbui C., Cipriani A., Patel V., et al. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry. 2011; 198(1): 11–1. PMID: 21200071


Views: 12916

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2218-7332 (Print)
ISSN 2658-3348 (Online)